Alcoholism: Beliefs and attitudes among Canadian alcoholism treatment practitioners

Canadian Journal of Psychiatry

Volumn 46, Issue 2, 2001, Pages 167-172

  Meza, Eduardo E ^a   Cunningham, John A ^a,b   El Guebaly, Nady ^c,d   Couper, Linda ^a,e  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d FOOTHILLS HOSPITAL   (Canada)

^e Georgian College   (Canada)

Author keywords

Alcoholism; Dissemination; Pharmacotherapy; Therapist attitudes

Indexed keywords

CALCIUM CARBIMIDE; DISULFIRAM; NALTREXONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ALCOHOLISM; ARTICLE; CANADA; COUNSELING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN ATTITUDE; SOCIAL WORKER; STATISTICAL ANALYSIS;

EID: 0035073206     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370104600209     Document Type: Article

References (34)

1. Closing the gap between alcoholism research and practice: The case for pharmacotherapy
2. Conference summary: Consensus conference on alcohol dependence and the role of pharmacotherapy in its treatment
3. Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism
4. Pharmacotherapies for alcoholism: Promising agents and clinical issues
5. Pharmacotherapies for alcohol problems: A review of research with focus on developments since 1991
6. Pharmacotherapy of alcoholism update
7. Prospects for a rational pharmacotherapy of alcoholism
8. Recent developments in the pharmacotherapy of alcohol dependence
9. Naltrexone and coping skills therapy for alcohol dependence. A controlled study
10. Naltrexone in the treatment of alcohol dependence
11. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression
12. Why do we need technology transfer in the substance abuse field?
13. Dissemination of research results regarding the pharmacotherapy of substance abuse: Case examples and critical review
14. Curative factors in alcohol and drug treatment: Behavioral and disease model perspectives
15. Coefficient alpha and the internal structure of tests
16. Alcoholics Anonymous and behavior therapy: Can habits be treated as diseases? Can diseases be treated as habits?
17. Cognitive processes and change in disease-model treatment
18. Addiction is a brain disease, and it matters
19. Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes
20. The effects of psychosocial services in substance abuse treatment
21. Recovery from alcohol problems with and without treatment: Prevalence in two population surveys
22. Resolution from alcohol problems with and without treatment: The effects of different problem criteria
23. Psychiatrists and the treatment of addictions: Perceptions and practices
24. Physician certification in alcohol and drug dependence
25. Addiction psychiatry: Challenges for a new psychiatric subspecialty
26. Implications of mental and substance use disorders: A comparison of single and dual diagnosis patients
27. Symptom severity and utilization of treatment resources among dually diagnosed patients
28. The self-medication hypothesis of addictive disorders: Focus on heroin and cocaine dependence
29. The self-medication hypothesis of substance use disorders: A reconsideration and recent applications